[go: up one dir, main page]

EA199900421A1 - Бензонафтиридины в качестве бронхиальных терапевтических средств - Google Patents

Бензонафтиридины в качестве бронхиальных терапевтических средств

Info

Publication number
EA199900421A1
EA199900421A1 EA199900421A EA199900421A EA199900421A1 EA 199900421 A1 EA199900421 A1 EA 199900421A1 EA 199900421 A EA199900421 A EA 199900421A EA 199900421 A EA199900421 A EA 199900421A EA 199900421 A1 EA199900421 A1 EA 199900421A1
Authority
EA
Eurasian Patent Office
Prior art keywords
petrophydridine
therapeutic tools
bronchial therapeutic
bronchial
compounds
Prior art date
Application number
EA199900421A
Other languages
English (en)
Other versions
EA001551B1 (ru
Inventor
Биате Гуттерер
Германн Амшлер
Вольф-Рюдигер Ульрих
Томас Мартин
Томас Бэр
Армин Хатцельманн
Карл Зандерс
Рольф Беуме
Хильдегард Босс
Дитрих Хэфнер
Ханс-Петер Клей
Карл-Йозеф Гёбель
Original Assignee
Бык Гюльден Ломберг Хемише Фабрик Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Бык Гюльден Ломберг Хемише Фабрик Гмбх filed Critical Бык Гюльден Ломберг Хемише Фабрик Гмбх
Publication of EA199900421A1 publication Critical patent/EA199900421A1/ru
Publication of EA001551B1 publication Critical patent/EA001551B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Abstract

В заявке описаны соединения формулы (I)в которой R1, R2, R3 и R4 имеют значения, указанные в описании. Эти соединения являются новыми эффективными средствами терапии бронхиальных заболеваний.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA199900421A 1996-11-11 1997-11-05 Бензонафтиридины в качестве бронхиальных терапевтических средств EA001551B1 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19646298 1996-11-11
EP96118188 1996-11-13
DE19739056 1997-09-05
PCT/EP1997/006096 WO1998021208A1 (en) 1996-11-11 1997-11-05 Benzonaphthyridines as bronchial therapeutics

Publications (2)

Publication Number Publication Date
EA199900421A1 true EA199900421A1 (ru) 1999-10-28
EA001551B1 EA001551B1 (ru) 2001-04-23

Family

ID=27216810

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199900421A EA001551B1 (ru) 1996-11-11 1997-11-05 Бензонафтиридины в качестве бронхиальных терапевтических средств

Country Status (30)

Country Link
US (1) US6008215A (ru)
EP (1) EP0937074B1 (ru)
JP (1) JP4223075B2 (ru)
KR (1) KR100484045B1 (ru)
CN (1) CN1090188C (ru)
AT (1) ATE234300T1 (ru)
AU (1) AU733129B2 (ru)
BG (1) BG63695B1 (ru)
BR (1) BR9713338B1 (ru)
CA (1) CA2270964C (ru)
CY (1) CY2476B1 (ru)
CZ (1) CZ288752B6 (ru)
DE (1) DE69719778T2 (ru)
DK (1) DK0937074T3 (ru)
EA (1) EA001551B1 (ru)
EE (1) EE03829B1 (ru)
ES (1) ES2195189T3 (ru)
GE (1) GEP20012390B (ru)
HU (1) HU226981B1 (ru)
ID (1) ID22042A (ru)
IL (1) IL129054A (ru)
NO (1) NO312764B1 (ru)
NZ (1) NZ334976A (ru)
PL (1) PL189641B1 (ru)
PT (1) PT937074E (ru)
RS (1) RS49607B (ru)
SI (1) SI0937074T1 (ru)
SK (1) SK283269B6 (ru)
TR (1) TR199900856T2 (ru)
WO (1) WO1998021208A1 (ru)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1075477T1 (en) 1998-05-05 2003-08-31 Altana Pharma Ag Novel Benzonaphthyridine-N-oxides
ES2224745T3 (es) * 1998-08-31 2005-03-01 Altana Pharma Ag N-oxidos de benzonaftiridina con actividad inhibidora de pde3 y pde4.
IT1303272B1 (it) 1998-10-29 2000-11-06 Zambon Spa Derivati triciclici inibitori della fosfodiesterasi 4
AU2290000A (en) 1999-01-15 2000-08-01 Byk Gulden Phenanthridine-n-oxides with pde-iv inhibiting activity
CA2360386A1 (en) * 1999-01-15 2000-07-20 Beate Gutterer Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity
ES2242594T3 (es) 1999-01-15 2005-11-16 Altana Pharma Ag N-oxidos de fenantridinas con una acitvidad inhidora de pde-iv.
PL205670B1 (pl) * 1999-01-15 2010-05-31 Nycomed Gmbh Nowa 6-fenylofenantrydyna, jej zastosowanie oraz lek zawierający ten związek
HRP20020158B1 (en) * 1999-08-21 2007-08-31 Altana Pharma Ag Action of synergistic combination
NL1017973C2 (nl) * 2000-05-10 2002-11-08 Tristem Trading Cyprus Ltd Inrichting.
EP1377574B1 (en) * 2001-02-21 2005-01-19 Byk Gulden Lomberg Chemische Fabrik GmbH 6-phenylbenzonaphthyridines
US6479493B1 (en) 2001-08-23 2002-11-12 Cell Pathways, Inc. Methods for treatment of type I diabetes
CA2495603A1 (en) * 2002-08-17 2004-03-04 Altana Pharma Ag Benzonaphthyridines with pde 3/4 inhibiting activity
DE60313331T2 (de) * 2002-09-04 2008-01-03 Nycomed Gmbh Neue benzonaphthyridine
US7470704B2 (en) * 2002-09-04 2008-12-30 Nycomed Gmbh Benzonaphthyridines
MXPA05010373A (es) 2003-04-01 2005-12-05 Applied Research Systems Inhibidores de fosfodiesterasas en infertilidad.
AR049419A1 (es) * 2004-03-03 2006-08-02 Altana Pharma Ag Hidroxi-6-fenilfenantridinas sustituidas con heterociclilo
EA017282B1 (ru) 2004-03-03 2012-11-30 Никомед Гмбх Производное гидрокси-6-гетероарилфенантридина и его применение в качестве ингибитора pde4
MXPA06009892A (es) * 2004-03-10 2007-03-01 Altana Pharma Ag Nuevas hidroxi-6-fenilfenantridinas sustituidas con amido y su uso como inhibidores de la fosfodiesterasa tipo 4 (pde4).
CA2559200A1 (en) * 2004-03-17 2005-09-29 Altana Pharma Ag Novel n- (alkoxyalkyl) carbamoyl - substituted 6-phenyl-benzonaphthyridine derivatives and their use as pde3/4 inhibitors
WO2006027344A2 (en) * 2004-09-08 2006-03-16 Altana Pharma Ag 3-oxa-10-aza-phenanthrenes as pde4 or pde3/4 inhibitors
US7589205B2 (en) * 2004-09-08 2009-09-15 Nycomed Gmbh 3-thia-10-aza-phenanthrene derivatives
DK1856093T3 (da) 2005-03-02 2010-03-15 Nycomed Gmbh (2R,4aR,10bR)-6-(2,6-dimethoxypyridin-3-yl)-9-ethoxy-8-methoxy-1,2,3,4,4a,10b-hexahydrophenanthridin-2-ol, HCI-salt
US20090221664A1 (en) 2005-10-19 2009-09-03 Abhijit Ray Pharmaceutical compositions of muscarinic receptor antagonists
TW200808695A (en) * 2006-06-08 2008-02-16 Amgen Inc Benzamide derivatives and uses related thereto
CA2974246C (en) * 2006-09-01 2020-02-25 Senhwa Biosciences, Inc. Tricyclic heteroaryl compounds and their use as protein modulators
JP5658138B2 (ja) 2008-04-23 2015-01-21 ライジェル ファーマシューティカルズ， インコーポレイテッド 代謝障害の処置のためのカルボキサミド化合物
AR079451A1 (es) 2009-12-18 2012-01-25 Nycomed Gmbh Compuestos 3,4,4a,10b-tetrahidro-1h-tiopirano[4,3-c]isoquinolina
CN108299429B (zh) * 2018-04-09 2021-10-08 中南大学 一类八氢苯并萘啶化合物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3899494A (en) * 1970-05-13 1975-08-12 Sandoz Ltd Substituted 6-phenyl benzo-naphthyridines
EP0247971A3 (en) * 1986-05-29 1990-01-17 Sandoz Ag Novel pharmaceutical compositions comprising and use of cis-6-(4-acetanilido)-8,9-dimethoxy-2-methyl-1,2,3,4,4a,10b-hexahydrobenzo[c][1,6]naphthyridin
MY105344A (en) * 1990-05-16 1994-09-30 Byk Gulden Lomberg Chemische Fabrik New sulphonyl compounds

Also Published As

Publication number Publication date
JP2001503442A (ja) 2001-03-13
AU733129B2 (en) 2001-05-10
EP0937074B1 (en) 2003-03-12
HUP0000426A2 (hu) 2001-02-28
DE69719778D1 (de) 2003-04-17
SK62399A3 (en) 1999-10-08
IL129054A0 (en) 2000-02-17
CN1090188C (zh) 2002-09-04
ATE234300T1 (de) 2003-03-15
ES2195189T3 (es) 2003-12-01
BG103310A (en) 2000-05-31
PT937074E (pt) 2003-07-31
KR100484045B1 (ko) 2005-04-20
SI0937074T1 (en) 2003-08-31
CZ288752B6 (cs) 2001-08-15
ID22042A (id) 1999-08-26
US6008215A (en) 1999-12-28
KR20000053100A (ko) 2000-08-25
BR9713338A (pt) 2000-05-09
WO1998021208A1 (en) 1998-05-22
IL129054A (en) 2002-07-25
DK0937074T3 (da) 2003-06-23
PL189641B1 (pl) 2005-09-30
BR9713338B1 (pt) 2009-12-01
YU19499A (sh) 2001-09-28
NZ334976A (en) 2000-10-27
NO312764B1 (no) 2002-07-01
CA2270964A1 (en) 1998-05-22
GEP20012390B (en) 2001-03-25
AU5317098A (en) 1998-06-03
NO992282D0 (no) 1999-05-11
CA2270964C (en) 2007-07-31
PL333429A1 (en) 1999-12-06
EA001551B1 (ru) 2001-04-23
JP4223075B2 (ja) 2009-02-12
SK283269B6 (sk) 2003-04-01
HUP0000426A3 (en) 2001-04-28
EE03829B1 (et) 2002-08-15
BG63695B1 (bg) 2002-09-30
NO992282L (no) 1999-05-11
EE9900105A (et) 1999-10-15
EP0937074A1 (en) 1999-08-25
CY2476B1 (en) 2005-05-03
CZ167599A3 (cs) 1999-11-17
DE69719778T2 (de) 2004-02-05
RS49607B (sr) 2007-06-04
HU226981B1 (hu) 2010-04-28
CN1236367A (zh) 1999-11-24
HK1022151A1 (en) 2000-07-28
TR199900856T2 (xx) 1999-07-21

Similar Documents

Publication Publication Date Title
EA199900421A1 (ru) Бензонафтиридины в качестве бронхиальных терапевтических средств
EA199900620A1 (ru) Фталазиноны
EA199800667A1 (ru) Новые фенантридины
EA200001224A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
EA199900494A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
EA200001223A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
EA200000759A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
EA200100315A1 (ru) Простые тетрагидропиридовые эфиры
EA199900936A1 (ru) Фунгицидные трифторметилалкиламинотриазолопиримидины
EA200200097A1 (ru) Имидазоимидазолы и триазолы в качестве противовоспалительных агентов
EA200400648A1 (ru) N, n'-замещенные производные 1,3-диамино-2-гидроксипропана
EA199900758A1 (ru) Малые молекулы, полезные при лечении воспалительных заболеваний
EA200000920A1 (ru) Производные бициклических гидроксамовых кислот
EA200100731A1 (ru) Фенилфенантридины с ингибирующей фдэ-4 активностью
EA200100412A1 (ru) Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ
BG101284A (bg) Съединения и методи за лечение на рак
EA199900643A1 (ru) Сульфамидные ингибиторы металлопротеаз
EA200300929A1 (ru) Новые лекарственные композиции на основе антихолинергических средств и ингибиторов pde-iv
EA200300171A1 (ru) Циклопентаноиндолы, композиции, содержащие данные соединения, и способы лечения
EA200500856A1 (ru) Новые химические соединения
EA200300836A1 (ru) Производные фталазинон-пиперидина в качестве ингибиторов pde4
DE69735442D1 (de) Antidiabetische mittel
IT1285770B1 (it) Composti corticoidei
EA200100204A1 (ru) Фармацевтические агенты для лечения болезни паркинсона, ганв и микроаденом
EA200200381A1 (ru) Тетрагидротиопиранфталазиноновые производные в качестве ингибиторов pde4

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM

PD4A Registration of transfer of a eurasian patent in accordance with the succession in title
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY

PD4A Registration of transfer of a eurasian patent in accordance with the succession in title
PD4A Registration of transfer of a eurasian patent in accordance with the succession in title
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU